Caption Management, LLC Eli Lilly & CO Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $173,880 - $239,719	400 Added 2.27%	18,000 $9.67 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $6.98 Million - $9.33 Million	-19,900 Reduced 53.07%	17,600 $8.25 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $11.6 Million - $13.7 Million	37,500 New	37,500 $12.9 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $5.19 Million - $5.91 Million	17,500 New	17,500 $5.66 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $21.1 Million - $26.2 Million	-90,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $20.2 Million - $25.1 Million	90,000 New	90,000 $24.9 Million

4,003

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.